Back to mobile site

Goldman Sachs Comments on Amgen (AMGN)

May 3, 2024 5:53 AM EDT Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Conviction Buy rating and $350.00 price target on Amgen (NASDAQ: AMGN)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login